![](https://investorshub.advfn.com/uicon/77609.png?cb=1485869477)
Monday, July 25, 2016 6:37:19 PM
Specific duties and responsibilities include:
* Contribute to the development and execution of a US customer level business plan in order to maximize the launch of Glatopa 40mg/mL into the US neurology market
* Contribute to the strategic segmentation of the US neurology market for Glatopa 40mg/mL and identification of target customers
Dew is correct - at risk 40mg. launch seems quite likely for 2/2017 if FDA approval is granted this year.
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM